Upcoming Event: World Biomarkers and Companion Diagnostics Summit Asia
6/21/2011
Event:
World Biomarkers and Companion Diagnostics Summit Asia
Dates: September 12 - 14, 2011
Venue: TBD, Hong Kong
Contact: Joshua Lowth
Email: Joshua.Lowth@hansonwade.com
The
World Biomarkers and Companion Diagnostics Summit Asia is the perfect place to meet drug and diagnostic industry leaders to learn the latest approaches to turn biomarker research into successful patient stratification. We’re bringing together a
unique blend of experiences from the East and West so that you can:
- Find out how you can add value to your drug development and improve market adoption with a drug-diagnostic development approach;
- Understand the current pharmaceutical and diagnostic marketplace in Asia, the key differences between East and West and how you can make personalized medicine and companion diagnostics a commercially viable opportunity for you;
- Develop new tactics to harness drug response variability and turn biomarker research into stratified patient populations for clinical and commercial success;
- Get the latest insights on the Asian regulatory requirements for drugs and diagnostics, biomarker-driven clinical trial operation and reimbursement of personalized medicines;
- Explore the biomarker partnership opportunities in Asia and understand how companion diagnostic deals will play out in this marketplace; and
- Learn how to implement a biomarker and companion diagnostic strategy into your pipeline to improve your chances of drug success.
Featuring presentations from: GSK, Astellas Pharma, Eisai, Roche, Pfizer, MSD, Chugai Pharmaceutical Co., Beigene, Genentech, Novartis, Bayer and Merck.